TempraMed Signs Two-Year Exclusive UK Distribution Agreement for VIVI Epi
TempraMed signed an exclusive UK distribution agreement with Poole Bay Holdings. The two-year deal includes approximately US$198,000 in potential purchases and targets school networks and other UK channels.
Story updates
12:08:01 PM UTC
SquawkNews
TempraMed's subsidiary signed a 24-month exclusive UK distribution agreement for VIVI Epi, with minimum-volume targets representing approximately US$198K in potential purchases. Commercial sales are subject to UK regulatory registrations and requirements.Material DetailsContext by AI AnalystThis is…